Item 5.07. Submission of Matters to a Vote of Security Holders.
As previously reported, Soligenix, Inc. (the “Company”) initially convened its 2023 Annual Meeting of Stockholders (the “Meeting”). As there was not a sufficient number of shares of the Company’s common stock present or represented by proxy in order to a constitute quorum, the Company adjourned the initial session of the Meeting on September 21, 2023 and the reconvened sessions of the Meeting on October 18, 2023 and November 16, 2023, without transaction any business.
On December 15, 2023, the Meeting reconvened. There being a sufficient number of shares of the Company’s common stock present or represented by proxy in order to a constitute quorum, the following items were voted upon:
Proposal One | Election of Directors: |
The following five nominees were elected as directors to serve until the 2024 Annual Meeting of Stockholders by votes as follows:
| | | | | | | | |
Name | | For | | | Withheld | |
Christopher J. Schaber, PhD | | | 2,392,737 | | | | 1,519,856 | |
Gregg A. Lapointe, CPA, MBA | | | 2,648,262 | | | | 1,264,331 | |
Diane L. Parks, MBA | | | 2,622,353 | | | | 1,290,240 | |
Robert J. Rubin, MD | | | 2,408,798 | | | | 1,503,795 | |
Jerome B. Zeldis, MD, PhD | | | 2,404,068 | | | | 1,508,525 | |
There were 1,602,901 broker non-votes in the election of directors.
Proposal Two | Non-binding advisory vote on executive compensation: |
The proposal to approve, by a non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed in the Company’s 2023 proxy statement was approved, and the votes were as follows:
For | | Against | | Abstain |
2,315,274 | | 707,529 | | 889,790 |
There were 1,602,901 broker non-votes on this proposal.
Proposal Three | Ratification of the Appointment of Independent Registered Public Accounting Firm: |
The proposal to ratify the appointment of Cherry Bekaert LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023 was approved by votes as follows:
| | | | |
For | | Against | | Abstain |
4,439,358 | | 188,624 | | 887,512 |
There were no broker non-votes on this proposal.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits.
| | |
| | |
Exhibit No. | | Description |
104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document) |